Canonica, G. W., Harrison, T. W., Chanez, P., Menzella, F., Louis, R., Cosio, B. G., . . . Garcia Gil, E. (2022). Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis. Allergy, 77(1), 150. https://doi.org/10.1111/all.14902
Chicago Style (17th ed.) CitationCanonica, Giorgio Walter, et al. "Benralizumab Improves Symptoms of Patients with Severe, Eosinophilic Asthma with a Diagnosis of Nasal Polyposis." Allergy 77, no. 1 (2022): 150. https://doi.org/10.1111/all.14902.
MLA (9th ed.) CitationCanonica, Giorgio Walter, et al. "Benralizumab Improves Symptoms of Patients with Severe, Eosinophilic Asthma with a Diagnosis of Nasal Polyposis." Allergy, vol. 77, no. 1, 2022, p. 150, https://doi.org/10.1111/all.14902.